Market News & Trends
Mitsubishi Gas Chemical Develops First-Ever, PFAS-Free Oxygen Absorber to Help the Industry Meet Emerging Global Regulations
In response to the growing legislation around per- and polyfluoroalkyl substances (PFAS), Mitsubishi Gas Chemical (MGC) has launched the first future-proof, eco-friendly packaging solution for the industry using a cleaner chemistry within record-breaking turnaround…..
BioNTech Completes Acquisition of InstaDeep
BioNTech SE recently announced the completion of the acquisition of InstaDeep Ltd., a leading global technology company in the field of artificial intelligence (AI) and…
Bora Pharmaceuticals Unveils Eye-Opening New Facility for Ophthalmic Manufacturing
Bora Pharmaceuticals recently announce the opening of a new state-of-the-art facility in Taoyuan City, Taiwan. Officially opened by Bora Pharmaceuticals CEO Bobby Sheng and President of….
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
PharmAla Biotech Holdings Inc. recently announced it has filed a patent on the composition of matter of PharmAla-1. The patent filing follows a year of preclinical…
First Wave BioPharma Announces Initial Topline Results From Phase 2 Trial Investigating Enhanced Adrulipase Formulation
First Wave BioPharma, Inc. recently announced it has received topline results from its Phase 2 SPAN clinical trial investigating an enhanced enteric microgranule delivery formulation of adrulipase for the treatment of exocrine pancreatic….
George Medicines Completes Recruitment of first Phase 3 Hypertension Trial Investigating Novel Single-Pill Triple Combination Candidate
George Medicines recently announced all patients have been enrolled in its Phase 3 active-controlled trial evaluating the efficacy and safety of GMRx2, the company’s….
Centogene Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
CENTOGENE N.V. recently announced the publication of a landmark study titled At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over…
NodThera is First to Demonstrate Reduction in Neuroinflammation in the Clinic With Brain Penetrant NLRP3 Inflammasome Inhibitor
NodThera recently announced positive, initial data from four subjects in the elderly volunteer stage of its Phase 1b/2a study evaluating the effects of its lead…
Gerresheimer Launches Open Innovation Program for the Development of Home Therapy Solutions
As an innovative system and solution provider, Gerresheimer is the global partner for the pharma and biotech industry. In collaboration with ekipa, a leading incubator for open innovation, Gerresheimer is calling on start-ups, companies, students, researchers, and….
Kindeva Drug Delivery, Chiesi Group & H&T Presspart Announce Strategic Partnership for Dose Counter Technology Production
Kindeva Drug Delivery and H&T Presspart are partnering with Chiesi Group for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Combining the specific….
Ocean Biomedical’s mRNA-based Vaccine Candidate Generates Over 90% Killing of Malaria Parasites in Non-human Primates, Demonstrating Broad Potential to Address Global & Emerging US Malaria Challenges
Ocean Biomedical, Inc. recently announced it is focusing its multi-pronged malaria program to address the chronic malaria crisis in sub-Saharan Africa while recognizing newly emerging…
Akari Therapeutics Provides Update on Development of Long-Acting PAS-Nomacopan for Treatment of Geographic Atrophy
Akari Therapeutics, Plc recently announced updates on the development of long-acting PAS-nomacopan as a potential treatment for geographic atrophy (GA). Resulting from extensive preclinical development…
Daré Bioscience Announces Additional Positive Data from Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women
Daré Bioscience, Inc. and its collaborator Strategic Science & Technologies, LLC (SST) recently announced additional positive data from the exploratory Phase 2b RESPOND study evaluating…
Purple Biotech Reports Positive Results of CM24 Dose Escalation in Advanced Pancreatic Cancer Patients
Purple Biotech Ltd. recently announced the completion and data maturity of its Phase 1 dose escalation study of CM24, a first-in-class anti-CEACAM1 monoclonal antibody addressing…
Eloxx Pharmaceuticals Announces Publication Demonstrating the Power of its TURBO-ZM Platform to Target the Human Ribosome for Therapeutic Benefit
Eloxx Pharmaceuticals, Inc. recently announced that Cancer Research Communications has published A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target…
Tonix Pharmaceuticals Announces Initiation of Enrollment in MGH Phase 2 POWER Study of Intranasal Potentiated Oxytocin for the Treatment of Pediatric Obesity
Tonix Pharmaceuticals Holding Corp. recently announced the first participant was enrolled in the Phase 2 POWER study of TNX-1900 (intranasal potentiated oxytocin) for the treatment…
ZyVersa Therapeutics Announces Publication That Demonstrates Role of Inflammasome Activation in Hypertrophic Heart Disease Induced by Mechanical Stress
ZyVersa Therapeutics, Inc. recently announced publication of an article in the peer-reviewed journal Circulation demonstrating the role of inflammasome NLRP3 activation in hypertrophic heart disease induced…
Acquisition of Solus BioTech Expands Croda's Specialized Pharma Business in Asia
Croda International Plc recently announced it has acquired Solus BioTech, a global leader in premium, biotechnology-derived materials, from Solus Advanced Materials…..
LIfT BioSciences Heralds a New Era of Affordable Effective Cancer Cell Therapies Simply Produced From iPSCs
LIfT BioSciences recently announced successful proof-of-concept production of its patented cancer killing alpha neutrophils from induced….
Caribou Biosciences Announces $25-Million Equity Investment From Pfizer
Caribou Biosciences, Inc. recently announced Pfizer Inc. has made a $25-million equity investment in the company. Pfizer purchased 4,690,431 of Caribou common shares at a price of….
